Fred Hutchinson Cancer Center: Melanoma trials
The registry lists 16 Melanoma studies with Fred Hutchinson Cancer Center as lead sponsor. 3 are open to participants now and 2 have results posted.
Phase 1 10Phase 2 8No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialNot yet recruitingNCT07576725Phase 2
- High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO TrialRecruitingNCT06298734Not applicable
- Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung CancerRecruitingNCT05098210Phase 1
- Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV MelanomaCompletedNCT01961115Phase 2Results posted
- Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic MelanomaCompletedNCT01807182Phase 2Results posted
- Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic MelanomaCompletedNCT01339663Phase 1
- Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Metastatic MelanomaTerminatedNCT01106235Phase 1
- Cyclophosphamide, Autologous Lymphocytes, and Aldesleukin in Treating Patients With Metastatic MelanomaNo longer availableNCT01005537
- Therapeutic Autologous Lymphocytes, Aldesleukin, and Denileukin Diftitox in Treating Patients With Stage III-IV MelanomaTerminatedNCT00945269Phase 1/2
- Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic MelanomaCompletedNCT00871481Phase 1/2
- Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV MelanomaCompletedNCT00553306Phase 1/2
- Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV MelanomaCompletedNCT00317759Phase 1
- Biological Therapy in Treating Patients With Metastatic MelanomaCompletedNCT00045357Phase 1
- Biological Therapy in Treating Patients With Metastatic MelanomaCompletedNCT00045149Phase 1
- Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV MelanomaCompletedNCT00006233Phase 2
- Biological Therapy in Treating Patients With Metastatic MelanomaCompletedNCT00002786Phase 1/2